Grant: CIHR Fellowship
University of Toronto
$135,000.00
Investigating the role of FAM72A in B cell antibody diversification
FY 2019-20
Summary
Antibodies, also referred to as immunoglobulins (Ig), play fundamental roles in our immune system by providing protection against pathogens. Antibodies are "Y" shaped molecules produced by specialized immune cells called the B cells. The tips of the two arms of the "Y", named the variable regions, differ greatly among different antibodies, thus providing the antibodies with the specificity and diversity for binding pathogens. The stem of the "Y" is named the constant region and it determines the functional properties of the antibodies. Antibodies can be further divided into different classes, with different antibody classes adopting different modes of action, such as directly binding to microbes and neutralizing their effect, localizing antibodies to different tissues, and signalling other immune cells to kill the infecting microbes or microbe-infected host cells. Upon exposure to an antigen, antibodies undergo diversification process to strength their abilities to bind and neutralize antigens. Somatic hypermutation and class switch recombination, both initiated by an enzyme named AID, are two genetic mechanisms that enable B cells to produce antibodies with higher antigen binding affinities and different classes. Our current knowledge towards somatic hypermutation and class switch recombination is likely incomplete, as complex and multifaceted molecular events take place during these two processes. Through a genetic screen I have identified FAM72A as a novel gene that functions in antibody class switch recombination, and propose to fully characterize the role of this gene and its product during antibody diversification using mouse models and diverse biochemical and cellular experimentations. My proposed work will advance our understanding on how antibody diversity is achieved, and influence vaccine development or the generation of therapeutic agents that target specific B cell malignancies.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
412948
Name
Feng Yuqing
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Investigating the role of FAM72A in B cell antibody diversification
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Activation-Induced Cytidine Deaminase; Antibodies; B Cells; Class Switch Recombination; Dna Damage And Repair; Genetic Screen; Somatic Hypermutation
Abstract
Antibodies, also referred to as immunoglobulins (Ig), play fundamental roles in our immune system by providing protection against pathogens. Antibodies are "Y" shaped molecules produced by specialized immune cells called the B cells. The tips of the two arms of the "Y", named the variable regions, differ greatly among different antibodies, thus providing the antibodies with the specificity and diversity for binding pathogens. The stem of the "Y" is named the constant region and it determines the functional properties of the antibodies. Antibodies can be further divided into different classes, with different antibody classes adopting different modes of action, such as directly binding to microbes and neutralizing their effect, localizing antibodies to different tissues, and signalling other immune cells to kill the infecting microbes or microbe-infected host cells. Upon exposure to an antigen, antibodies undergo diversification process to strength their abilities to bind and neutralize antigens. Somatic hypermutation and class switch recombination, both initiated by an enzyme named AID, are two genetic mechanisms that enable B cells to produce antibodies with higher antigen binding affinities and different classes. Our current knowledge towards somatic hypermutation and class switch recombination is likely incomplete, as complex and multifaceted molecular events take place during these two processes. Through a genetic screen I have identified FAM72A as a novel gene that functions in antibody class switch recombination, and propose to fully characterize the role of this gene and its product during antibody diversification using mouse models and diverse biochemical and cellular experimentations. My proposed work will advance our understanding on how antibody diversity is achieved, and influence vaccine development or the generation of therapeutic agents that target specific B cell malignancies.
Competitiondate
201910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Feng, Yuqing
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~